A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation
Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O’Brien P, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002, 73: 1904-1909. PMID: 12131685, DOI: 10.1097/00007890-200206270-00009.Peer-Reviewed Original ResearchMeSH KeywordsColistinDouble-Blind MethodDrug Therapy, CombinationFemaleGentamicinsGram-Negative Aerobic BacteriaHumansIntestinesLiver TransplantationMaleMiddle AgedNystatinProspective StudiesYeastsConceptsSelective bowel decontaminationLiver transplantationRate of infectionDay 0Bowel decontaminationMedical careBacterial infectionsDouble-blinded fashionDouble-blinded evaluationGentamicin 80Mortal complicationsUncontrolled trialsSwab culturesTreatment groupsTransplantationPatientsDay 21Day 60Routine useInfectionPositive floraNegative floraFecal cultureCareDeath